Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic Adenocarcinoma

NCT04812808 is registered in ClinicalTrials.gov with Hôpital Fribourgeois as lead sponsor.

NCT NCT04812808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04812808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic Adenocarcinoma
Lead sponsor
Hôpital Fribourgeois
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2022
Completion date
May 31, 2024
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas cancer